This is the authors' abstract. We don't add key points for this paper.
We compared hypothetical willingness to use injectable pre-exposure prophylaxis among 116 HIV prevention-service clients at two Ugandan clinics. Willingness was 81.8% among current oral users, 42.4% among former users and 50.0% among never users. Compared with current users, age- and sex-adjusted prevalence ratios were 0.52 (95% confidence interval 0.34–0.78) and 0.60 (0.39–0.92), respectively. Neutral responses were common among former and never users. These findings support assessing information needs across oral-use histories and testing whether counselling and a real product offer translate stated willingness into initiation and continued use.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Olet et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: